163 related articles for article (PubMed ID: 18832811)
1. Anti-CTLA4 monoclonal antibody induced sarcoidosis in a metastatic melanoma patient.
Eckert A; Schoeffler A; Dalle S; Phan A; Kiakouama L; Thomas L
Dermatology; 2009; 218(1):69-70. PubMed ID: 18832811
[No Abstract] [Full Text] [Related]
2. Diagnosis of melanoma under concomitant natalizumab therapy.
Vavricka BM; Baumberger P; Russmann S; Kullak-Ublick GA
Mult Scler; 2011 Feb; 17(2):255-6. PubMed ID: 21177318
[No Abstract] [Full Text] [Related]
3. New-onset mediastinal and central nervous system sarcoidosis in a patient with metastatic melanoma undergoing CTLA4 monoclonal antibody treatment.
Murphy KP; Kennedy MP; Barry JE; O'Regan KN; Power DG
Oncol Res Treat; 2014; 37(6):351-3. PubMed ID: 24903767
[TBL] [Abstract][Full Text] [Related]
4. Alpha-interferon induced sarcoidosis mimicking metastatic melanoma.
North J; Mully T
J Cutan Pathol; 2011 Jul; 38(7):585-9. PubMed ID: 21521359
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary sarcoid-like granulomatosis induced by ipilimumab.
Berthod G; Lazor R; Letovanec I; Romano E; Noirez L; Mazza Stalder J; Speiser DE; Peters S; Michielin O
J Clin Oncol; 2012 Jun; 30(17):e156-9. PubMed ID: 22547608
[No Abstract] [Full Text] [Related]
6. Febrile neutropenia in a metastatic melanoma patient treated with ipilimumab - case report.
Woźniak S; Mackiewicz-Wysocka M; Krokowicz Ł; Kwinta Ł; Mackiewicz J
Oncol Res Treat; 2015; 38(3):105-8. PubMed ID: 25792081
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: Case series and immunophenotypic analysis.
Lomax AJ; McGuire HM; McNeil C; Choi CJ; Hersey P; Karikios D; Shannon K; van Hal S; Carr U; Crotty A; Gupta SK; Hollingsworth J; Kim H; Fazekas de St Groth B; McGill N
Int J Rheum Dis; 2017 Sep; 20(9):1277-1285. PubMed ID: 28480561
[TBL] [Abstract][Full Text] [Related]
8. A randomized phase 2 trial of bevacizumab with or without daily low-dose interferon alfa-2b in metastatic malignant melanoma.
Varker KA; Biber JE; Kefauver C; Jensen R; Lehman A; Young D; Wu H; Lesinski GB; Kendra K; Chen HX; Walker MJ; Carson WE
Ann Surg Oncol; 2007 Aug; 14(8):2367-76. PubMed ID: 17534686
[TBL] [Abstract][Full Text] [Related]
9. Nursing management of patients with metastatic melanoma receiving ipilimumab.
Bryce J; Passoni C
Oncol Nurs Forum; 2013 May; 40(3):215-8. PubMed ID: 23615135
[No Abstract] [Full Text] [Related]
10. Checkpoint inhibitor-induced sarcoid reaction mimicking bone metastases.
Jespersen H; Bjursten S; Ny L; Levin M
Lancet Oncol; 2018 Jun; 19(6):e327. PubMed ID: 29893264
[No Abstract] [Full Text] [Related]
11. Bilateral Facial Palsy following Ipilimumab Infusion for Melanoma.
Altman AL; Golub JS; Pensak ML; Samy RN
Otolaryngol Head Neck Surg; 2015 Nov; 153(5):894-5. PubMed ID: 26408564
[No Abstract] [Full Text] [Related]
12. Cutaneous sarcoidosis in a melanoma patient under Ipilimumab therapy.
Martínez Leboráns L; Esteve Martínez A; Victoria Martínez AM; Alegre de Miquel V; Berrocal Jaime A
Dermatol Ther; 2016 Sep; 29(5):306-308. PubMed ID: 27357143
[No Abstract] [Full Text] [Related]
13. Ipilimumab, a human monoclonal antibody for treatment of unresectable or metastatic melanoma.
Wilkes GM
Oncology (Williston Park); 2011 Jul; 25(7 Suppl Nurse Ed):46-7. PubMed ID: 25373277
[No Abstract] [Full Text] [Related]
14. Interferon-induced cutaneous sarcoidosis in melanoma.
Suárez-García C; Pérez-Gil A; Pereira-Gallardo S; Codes-Villena M; García-Escudero A; Miguel Camacho F
Melanoma Res; 2009 Dec; 19(6):391-4. PubMed ID: 19770687
[TBL] [Abstract][Full Text] [Related]
15. Ipilimumab-induced sarcoidosis in a patient with metastatic melanoma undergoing complete remission.
Vogel WV; Guislain A; Kvistborg P; Schumacher TN; Haanen JB; Blank CU
J Clin Oncol; 2012 Jan; 30(2):e7-e10. PubMed ID: 22124094
[No Abstract] [Full Text] [Related]
16. CTLA4-induced splenomegaly and a review of the literature pertaining to autoimmune complications of therapy.
Ezra N; Goltche NB; Hakimian S; Afari A
J Drugs Dermatol; 2010 Nov; 9(11):1432-6. PubMed ID: 21061768
[TBL] [Abstract][Full Text] [Related]
17. Sarcoid-like Granulomatous Intraocular Inflammation Caused by Vemurafenib Treatment for Metastatic Melanoma.
Eser Öztürk H; Süllü Y
Turk J Ophthalmol; 2020 Mar; 50(1):50-52. PubMed ID: 32167264
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary and cutaneous sarcoidosis associated with interferon therapy for melanoma.
Pelletier F; Manzoni P; Jacoulet P; Humbert P; Aubin F
Cutis; 2007 Nov; 80(5):441-5. PubMed ID: 18189032
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune response as a side effect of treatment with interferon-α in melanoma: does this have prognostic implications?
Palacios-Álvarez I; Román-Curto C; Mir-Bonafé JM; Cañueto J; Usero-Bárcena T; Fernández-López E
Int J Dermatol; 2015 Mar; 54(3):e91-3. PubMed ID: 25521221
[No Abstract] [Full Text] [Related]
20. [Pulmonary and renal involvement in a TNFα antagonist drug-induced sarcoidosis].
Olivier A; Gilson B; Lafontaine S; Pautot JX; Bindi P
Rev Med Interne; 2012 May; 33(5):e25-7. PubMed ID: 21592629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
